WHO issues warning on falsified medicines as Lilly warns patients about counterfeit and compounded medicinesThe World Health Organization (WHO) has issued a medical product alert on falsified semaglutides, the type of medicines that are used for...
Scottish Medicines Consortium accepts tirzepatide (Mounjaro) for obesity in eligible adultsThe Scottish Medicines Consortium (SMC) has accepted Eli Lilly and Company’s tirzepatide (Mounjaro) for restricted use within NHS...
Tirzepatide was superior to placebo for MASH resolutionResults from Eli Lilly and Company’s SYNERGY-NASH that evaluated the investigational use of tirzepatide in adults with biopsy-proven...
Tirzepatide effective even for those with diabetes and other complicationsHaving medical conditions linked to obesity does not impact the total weight loss achieved with the anti-obesity medication tirzepatide,...
Tirzepatide found to reduce body weight regardless of duration of condition and BMI before treatmentTwo studies presented at this year's European Congress on Obesity in Venice, Italy, have reported that tirzepatide consistently reduces...
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesityEli Lilly and Company has announced positive topline results from the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide...
Tirzepatide may help lower blood pressure in adults with obesityTirzepatide significantly lowered the systolic blood for nearly 500 adults with obesity who took the medication for about eight months,...